Trial Details
RECRUITINGBasic Information
| Clinical ID | c150 |
|---|---|
| Identifier | NCT07089420 |
| Trial Title | ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | IBD (Inflammatory Bowel Disease)|IBS - Irritable Bowel Syndrome|Crohn Disease (CD)|UC - Ulcerative Colitis |
| Interventions | DEVICE: ALPCO Calprotectin CLIA |
Participant Information
| Sponsor | American Laboratory Products Company |
|---|---|
| City | Salem |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2025-07-07 |
|---|---|
| Primary Completion Date | 2026-10 |
| Completion Date | 2026-10 |